Alliance for Human Research Protection Fri, 18 Jul 2003 Dear Dr. Campbell and others concerned about ethical research: This is in response to your July 11 comments objecting to AHRP’s criticism of the ethics of two controversial ARDS experiments sponsored by the . . . Continue reading →
John H. Noble
Antidepressants shown worthless for most consumers
The comments below expand upon an Infomail about the recently published JAMA meta-analysis.
ARDSNet – AHRP Reply to OHRP Response
THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Ave, Suite 28P New York, NY 10023 212-595-8974 ahrp@researchprotection.org September 4, 2002 Michael Carome, MD Associate Director for Regulatory Affairs Office for Human Research Protections The Tower Building 1101 Wootton Parkway, Suite . . . Continue reading →
OHRP Response to AHRP re: Surrogate Consent to Research
OHRP Response to AHRP re: Surrogate Consent to Research Office of the Secretary Department of Health & Human Services Office of Public Health and Science Office for Human Research Protections Rockville, Maryland E-mail: mcarome@osophs.dhhs.gov August 28, 2002 Vera Hassner Sharav President, The . . . Continue reading →
Protecting People w Mental Disabilities & Impairments against Biomedical Research Abuse
Protecting People with Mental Disabilities and Impairments against Biomedical Research Abuse[*] By John H. Noble, Jr., Ph.D, The Catholic University of America, Washington, DC, USA Vera Hassner Sharav, MLS, Alliance for Human Research Protection, New York, USA People with mental disabilities and . . . Continue reading →
Protecting Human Subjects in Research: Are Current Safeguards Adequate?
Protecting Human Subjects in Research: Are Current Safeguards Adequate? AHRP Testimony submitted to Congressional Committee April 23, 2002 Vera Hassner Sharav, President, and John H. Noble, Jr., Ph.D., steering committee member, The Alliance for Human Research Protection (AHRP), before the Subcommittee on . . . Continue reading →
Smallpox Vaccine Program snag–Union Workers demand Protections – WashPost
Smallpox Vaccine Program snag–Union Workers demand Protections – WashPost Fri, 17 Jan 2003 Assuming responsibility for one’s actions is one of the hall marks of morality. The Administration protects the vaccine manufacturers and administering agents from liability but resists providing compensation to . . . Continue reading →
AHRP Testimony: Protections for Foster Children Enrolled in Clinical Trials Submitted to Cong.Ways & Means Hearing
THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) https://www.ahrp.org 142 West End Ave. Suite 28P New York, NY 10023 Testimony by The Alliance for Human Research Protection Committee on Ways and Means Hearing on Protections for Foster Children Enrolled in Clinical Trials May . . . Continue reading →
Netracor J & J heart Drug May Raise Risk of Dying
Netracor J & J heart Drug May Raise Risk of Dying Wed, 20 Apr 2005 A new research challenges the safety level linked with the drug ‘Natretor.’ Scios Inc., a subsidiary of Johnson & Johnson is the maker of “Natrecor.” “Researchers say . . . Continue reading →
AHRP Comments Re: EPA Proposed Rule for Human Pesticide Research
AHRP Comments Re: EPA Proposed Rule for Human Pesticide Research Wed, 30 Nov 2005 Help us stop a proposed government policy that would lead to the proliferation of unthinkable human pesticide experiments such as the infamous CHEERS experiment. CHEERS was designed to . . . Continue reading →
Response to Washington Post Editorial
Response to Washington Post Editorial Wed, 30 Jun 2004 Today’s Washington Post editorial, Missing Drug Data, is divorced from reality. It is written by someone who clearly doesn’t understand the safety issues involved when doctors are kept ignorant of the risks of . . . Continue reading →
Infomail – August 20 B, 2001
August 20b, 2001 The Scientist News reports on AHRP as New Advocacy Group to Police Human Research A group of patient and social justice advocates plan to form an Alliance for Human Research Protection to provide oversight on clinical research from laypersons’ . . . Continue reading →